Householder Group Estate & Retirement Specialist’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-49
Closed -$18.4K 1353
2023
Q3
$18.4K Buy
+49
New +$18.9K 0.01% 658
2023
Q1
$17K Buy
+49
New +$14.3K 0.01% 677
2022
Q4
Sell
-148
Closed -$36K 1172
2022
Q3
$36K Buy
+148
New +$45.1K 0.01% 459

Other funds holding WST

Householder Group Estate & Retirement Specialist's WST Position: Q4 2023 in Review

Householder Group Estate & Retirement Specialist sold out of West Pharmaceutical (WST) in Q4 2023, closing a stake of 49 shares — an estimated $18.4K sold.

Householder Group Estate & Retirement Specialist first reported a position in WST in Q3 2022 and held it in 3 quarters. The position peaked at $36K in Q3 2022. 783 funds tracked by Wall St. Rank hold WST as of Q4 2023.

  • Householder Group Estate & Retirement Specialist reported no remaining West Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Householder Group Estate & Retirement Specialist sold 49 West Pharmaceutical shares in Q4 2023, an estimated $18.4K.
  • Householder Group Estate & Retirement Specialist first reported a position in West Pharmaceutical in Q3 2022 and held it in 3 quarters.
  • Householder Group Estate & Retirement Specialist's West Pharmaceutical position peaked at $36K in Q3 2022.
  • 783 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q4 2023, filed 23 Jan 2024.